You have 9 free searches left this month | for more free features.

Tocotrienol-rich fraction with tamoxifen

Showing 1 - 25 of 4,859

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Obesity Trial in Kuala Lumpur (Tocotrienol-rich fraction vitamin E (TRF), Placebo)

Completed
  • Obesity
  • Tocotrienol-rich fraction vitamin E (TRF)
  • Placebo
  • Kuala Lumpur, Malaysia
    National University Of Malaysia
Jun 7, 2023

Chronic Kidney Diseases, Hemodialysis, Microbiota Trial in Rio de Janeiro (Tocotrienol rich fraction)

Active, not recruiting
  • Chronic Kidney Diseases
  • +4 more
  • Tocotrienol rich fraction
  • Rio de Janeiro, RJ, Brazil
    Denise Mafra
Aug 11, 2021

Dietary Supplements Trial in Kaohsiung (DHEA, DHEA+CoQ10+Tocotrienol)

Recruiting
  • Dietary Supplements
  • DHEA
  • DHEA+CoQ10+Tocotrienol
  • Kaohsiung, Taiwan
    Department of Obstetrics and Gynecology, Kaohsiung Veterans Gene
Jul 21, 2022

End Stage Liver Disease, NASH - Nonalcoholic Steatohepatitis, NAFLD - Nonalcoholic Fatty Liver Disease Trial in Indianapolis

Recruiting
  • End Stage Liver Disease
  • +2 more
  • Tocotrienol (TCT)
  • Placebo
  • Indianapolis, Indiana
    IU Health Unviersity Hospital
Jan 19, 2022

Breast Cancer Female Trial in Kuala Lumpur (Tocotrienol-rich Fraction (TRF))

Unknown status
  • Breast Cancer Female
  • Tocotrienol-rich Fraction (TRF)
  • Kuala Lumpur, Malaysia
    University of Malaya Medical Center
Apr 18, 2019

Breast Cancer Trial in Milano (Tocotrienol)

Completed
  • Breast Cancer
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jul 29, 2020

Diabetes, Type 2, Platelet-rich Plasma, Stromal Vascular Fraction Trial in Jakarta Pusat (SVF and aaPRP)

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • SVF and aaPRP
  • Jakarta Pusat, Jakarta, Indonesia
    Hayandra Peduli Foundation
Jun 22, 2023

Wrinkle Trial in Pulau Pinang (Facial cream with 2% palm tocotrienols extract, Base cream)

Not yet recruiting
  • Wrinkle
  • Facial cream with 2% palm tocotrienols extract
  • Base cream
  • Pulau Pinang, Malaysia
    School of Pharmaceutical Sciences, Universiti Sains Malaysia
Mar 14, 2023

Colorectal Cancer Metastatic Trial in Vejle (drug, dietary supplement, other)

Recruiting
  • Colorectal Cancer Metastatic
  • Vejle, Denmark
    Department of Oncology, Vejle Hospital
Nov 17, 2022

Ovarian Failure, Perimenopausal Disorder, Hormone Disturbance Trial in Colchester (procedure, device, drug)

Active, not recruiting
  • Ovarian Failure
  • +2 more
  • lipoaspiration harvest tSVF
  • +5 more
  • Colchester, Vermont
    Fanny Island Campus Medical Building
Jul 18, 2022

Obesity, Heart Failure With Normal Ejection Fraction Trial in Richmond (UFA dietary recommendations)

Active, not recruiting
  • Obesity
  • Heart Failure With Normal Ejection Fraction
  • UFA dietary recommendations
  • Richmond, Virginia
    Virginia Commonwealth University
Nov 17, 2022

Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)

Not yet recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Method(s)1 Attribution
  • Method(s)2 Attribution,
  • Colorado Springs, Colorado
    PNAF Medical
Nov 23, 2023

Diabetic Foot Ulcer, Diabetes, Diabetic Foot Trial in Lahore (Control; Standard-of-care management, Only PRP injection, PRP +

Recruiting
  • Diabetic Foot Ulcer
  • +10 more
  • Control; Standard-of-care management
  • +3 more
  • Lahore, Punjab, Pakistan
    Stem Cell Laboratory, Jinnah Burn and Reconstructive Surgery Cen
Nov 3, 2022

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Atrial Fibrillation Trial in Kuala Lumpur (Tocotrienols, Placebo oral capsule)

    Completed
    • Atrial Fibrillation
    • Tocotrienols
    • Placebo oral capsule
    • Kuala Lumpur, Malaysia
      Institut Jantung Negara
    Aug 23, 2022

    Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • +7 more
    • Birmingham, Alabama
    • +499 more
    Nov 15, 2022

    Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,

    Not yet recruiting
    • Breast Atypical Hyperplasia
    • +3 more
    • Acolbifene Hydrochloride
    • +4 more
    • Duarte, California
    • +3 more
    Jul 11, 2023

    Bioavailability Trial in Stuttgart (Control beta-carotene supplement plus Placebo, Control beta-carotene supplement plus iron

    Completed
    • Bioavailability
    • iron and zinc suphate supplements
    • Stuttgart, Baden-Württemberg, Germany
      University of Hohenheim
    Apr 28, 2023

    Anal Fistula Trial (PRP and PRFG in treatment of anal fistula)

    Not yet recruiting
    • Anal Fistula
    • PRP and PRFG in treatment of anal fistula
    • (no location specified)
    Oct 15, 2023

    Colorectal Cancer Trial in Vejle (Irinotecan 165 mg/m2 iv, Oxaliplatin 85 mg/m2 iv, Calcium folinate 200 mg/m2 iv)

    Active, not recruiting
    • Colorectal Cancer
    • Irinotecan 165 mg/m2 iv
    • +5 more
    • Vejle, Denmark
      Department of Oncology, Vejle Hospital
    Aug 16, 2022

    Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)

    Active, not recruiting
    • Breast Cancer
    • Burbank, California
    • +227 more
    Nov 15, 2022

    Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Tampa, Florida
    • +1 more
    Jan 13, 2023

    Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v6 Trial in Puerto Rico, United States

    Active, not recruiting
    • Invasive Breast Carcinoma
    • +3 more
    • Bevacizumab
    • +4 more
    • Mobile, Alabama
    • +525 more
    Jan 28, 2023

    Atypical Hyperplasia, Lobular Carcinoma in Situ Trial in Rochester (Tamoxifen, Topical 4-OHT( 4-hydroxytamoxifen)gel 2 mg/each

    Recruiting
    • Atypical Hyperplasia
    • Lobular Carcinoma in Situ
    • Evanston, Illinois
    • +1 more
    Jan 20, 2023

    Estrogen-receptor Positive Premenopausal Early Breast Cancer

    Active, not recruiting
    • Early Breast Cancer
    • None intervention (observational study)
    • Aviano, Italy
    • +39 more
    Feb 7, 2023